Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells

Abstract

BackgroundCells of the tumor microenvironment are recognized as important determinants of the tumor biology. The adjacent non-malignant cells can regulate drug responses of the cancer cells by secreted paracrine factors and direct interactions with tumor cells.ResultsHuman mesenchymal stromal cells (MSC) actively contribute to tumor microenvironment. Here we focused on their response to chemotherapy as during the treatment these cells become affected. We have shown that the secretory phenotype and behavior of mesenchymal stromal cells influenced by cisplatin differs from the naïve MSC. MSC were more resistant to the concentrations of cisplatin, which was cytotoxic for tumor cells. They did not undergo apoptosis, but a part of MSC population underwent senescence. However, MSC pretreatment with cisplatin led to changes in phosphorylation profiles of many kinases and also increased secretion of IL-6 and IL-8 cytokines. These changes in cytokine and phosphorylation profile of MSC led to increased chemoresistance and stemness of breast cancer cells.ConclusionTaken together here we suggest that the exposure of the chemoresistant cells in the tumor microenvironment leads to substantial alterations and might lead to promotion of acquired microenvironment-mediated chemoresistance and stemness.

Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma

“…Unfortunately, responses were typically not durable, and the median PFS is only 3 months. The mechanism of development of chemotherapy resistance resulting in limited durability is likely multifactorial as noted in prior studies demonstrating chemotherapy resistance via specific molecular mechanisms and changes within the tumor microenvironment . Perhaps particularly relevant in MCC, chemotherapy suppresses the immune system.…”

Cisplatin-induced autophagy protects breast cancer cells from apoptosis by regulating yes-associated protein

“…Cisplatin is a chemotherapeutic agent used for treating various malignancies, and functions by causing lethal DNA damage and inducing apoptosis (24). Although there are obvious benefits of cisplatin-based treatment of breast cancer, accumulating evidence indicates that the efficacy of cisplatin is still a problem (25). Multiple mechanisms contribute to the efficacy of cisplatin treatment in cancer cells.…”

Senile Osteoporosis: The Involvement of Differentiation and Senescence of Bone Marrow Stromal Cells

“…Immunoregulatory activity is also altered, due to reduction in lymphocytes proliferation inhibition, impaired migration ability and increased proinflammatory cytokine secretion [39]. Furthermore, the increase in IL6, IL8 and galectin secretion is increased in senescent BMSCs during senile osteoporosis, which promotes tumorigenesis [40,41].…”